Part D "Doctor Shopping": GAO's Remedies Find Little Buy-In From CMS
Executive Summary
A Senate hearing examining the prevalence of “doctor shopping” by Medicare Part D enrollees revealed that CMS and the Government Accountability Office disagree on possible tools to address the issue, and perhaps more basically, who is responsible for implementing them.
You may also be interested in...
CVS Combats Opioid Abuse By Blocking Prescriptions From Suspect Physicians
National pharmacy chain also advocates for national prescription drug monitoring database, mandatory e-prescribing for controlled substances. The Pharmaceutical Care Management Association offers legislators pharmacy-related policy recommendations to curb abuse.
BCBS Opioid Abuse Plan Requires Authorization For Scripts Longer than 30 Days
Blue Cross Blue Shield of Massachusetts is implementing what it believes are industry-leading policies July 1 to restrain the abuse of opioid medications among its members.
CMS Takes Second Shot At Mandating “Trial Size” Prescriptions For Part D; Estimates Savings At $2.5 Billion By 2018
CMS once again has proposed mandating that Medicare Part D prescription drug plan sponsors offer a “trial size” of first-fill prescriptions for medications treating chronic conditions and, in a step further than the previous effort, mandated that the cost-sharing be prorated based on the daily cost of the drug.